Fig. 4d
收藏官方服务：
资源简介：
HER2 HBCx-5 fragment were engrafted into SHO mice. 35 days later, tumor-bearing mice were treated once weekly for eight consecutive weeks, with 0.05 mg/kg MICAB1 PBD1G-ADCs or IC-PDB1G. Tumor growth was followed over time (n=10 per group).
创建时间：
2021-04-23
